Zobrazeno 1 - 10
of 36
pro vyhledávání: '"D. Birra"'
Autor:
I. Pantano, D. Mauro, D. Simone, L. Costa, D. Capocotta, M. Raimondo, D. Birra, G. Cuomo, T. D'Errico, M. Ferrucci, F. Comentale, G. Italiano, P. Moscato, N. Pappone, R. Russo, S. Scarpato, R. Tirri, P. Buono, A. Postiglione, R. Guida, R. Scarpa, U. Trama, E. Tirri, F. Ciccia
Publikováno v:
Reumatismo, Vol 74, Iss 4 (2023)
Rheumatic musculoskeletal diseases or RMD [rheumatoid arthritis (RA) and spondyloarthritis (SpA)] are systemic inflammatory diseases for which there are no biomarkers capable of predicting treatments with a higher likelihood of response in naive pati
Externí odkaz:
https://doaj.org/article/7702f9ea3fe8477da5c23a54ef084f16
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A, Migliore, G, Gigliucci, D, Birra, R, Saporito, L, Cicerchia, U, Massafra, D, Integlia, M, Cassol
Publikováno v:
European review for medical and pharmacological sciences. 25(18)
A review of network meta-analysis to assess efficacy and safety of biologics for the treatment of psoriatic arthritis (PsA).A systematic search was conducted on electronic databases to identify Bayesian meta-analysis reporting clinical parameters of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9d29129315faa248cdfdcca175e3b010
https://pubmed.ncbi.nlm.nih.gov/34604966
https://pubmed.ncbi.nlm.nih.gov/34604966
Autor:
Vincenzo Zaccone, Angelo Zoli, Antonio Gasbarrini, Antonio Nesci, Luca Santoro, Giusy Peluso, Angelo Santoliquido, B. Giupponi, S. L. Bosello, A. Di Giorgio, D. Birra
Publikováno v:
Scandinavian Journal of Rheumatology. 49:68-74
Objective: The aim of the study was to investigate endothelial function in treatment-naive polymyalgia rheumatica (PMR) patients and its modification during steroid therapy, in relation to changes ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b0e414ac6fe5e9827fd57bddd6739d3
https://doi.org/10.1080/03009742.2019.1628297
https://doi.org/10.1080/03009742.2019.1628297
Autor:
Anna Laura Fedele, Maria Rita Gigante, Gianfranco Ferraccioli, D. Birra, Stefano Alivernini, Barbara Tolusso, Elisa Gremese, Giusy Peluso, Francesco Federico, Laura Bui, Dario Bruno, Luca Petricca
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-11 (2019)
Arthritis Research & Therapy
Arthritis Research & Therapy
Background Differential diagnosis among psoriatic arthritis (PsA) and seronegative rheumatoid arthritis (Abneg RA) can be challenging particularly in the clinical setting of peripheral phenotype and autoantibodies seronegativity. The aim of the study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beebbe0651f33ca6046c711e7c45b82d
http://link.springer.com/article/10.1186/s13075-019-1898-7
http://link.springer.com/article/10.1186/s13075-019-1898-7
Publikováno v:
Annals of the Rheumatic Diseases. 81:1292.1-1292
BackgroundBiologics, such as tumor necrosis factor inhibitors (TNFi), are highly effective in the treatment of inflammatory arthritis, i.e., rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA). The importance of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::782a7d0786c22ef4b8f8aab9a30d8e91
https://doi.org/10.1136/annrheumdis-2022-eular.1429
https://doi.org/10.1136/annrheumdis-2022-eular.1429
Autor:
Rosalba Caccavale, Alessio Altobelli, Vincenzo Bruzzese, Paola Conigliaro, Roberto Perricone, Marino Paroli, Maria Sole Chimenti, Palma Scolieri, Bruno Laganà, Elisa Gremese, Andrea Picchianti Diamanti, Giulia Lavinia Fonti, Luca Navarini, Erica De Martino, Rossana Scrivo, Flavia Sunzini, Fabrizio Conti, Giusy Peluso, Simonetta Salemi, Antonella Afeltra, Paola Triggianese, D. Birra
Secukinumab (SEC) is effective for ankylosing spondylitis (AS) and psoriatic arthritis (PsA) in randomized trials, but real-life data are lacking.Real-life, prospective observational study on 169 consecutive outpatients at baseline (T0) and at 6 (T6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9555a716f9e3cc624cd560cb49f278c
http://hdl.handle.net/11573/1404583
http://hdl.handle.net/11573/1404583
Autor:
Miriam Teoli, Annamaria Mazzotta, Ketty Peris, D. Birra, Claudio Bonifati, Elisa Gremese, Alessandra Galossi, Roberto Perricone, Dario Graceffa, Felice Sensi, Rosalba Caccavale, Nicoletta Bernardini, Gaia Moretta, Antonio Giovanni Richetta, Maria Sole Chimenti, Paola Sessa, Ester Del Duca, S. Urbani, Severino Persechino, Valentina Carboni, Giusy Peluso, Clara De Simone, Maria Esposito
Publikováno v:
Therapeutic Advances in Chronic Disease
Therapeutic Advances in Chronic Disease, Vol 10 (2019)
Therapeutic Advances in Chronic Disease, Vol 10 (2019)
Background: Consensus among dermatologists and rheumatologists in the diagnosis and assessment of musculoskeletal diseases in psoriasis (PsO) patients is needed. This study assesses characteristics of musculoskeletal pain in patients with PsO for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fd6ce6907e567f1101e5851a29bd1f9
https://pubmed.ncbi.nlm.nih.gov/31205645
https://pubmed.ncbi.nlm.nih.gov/31205645
Autor:
Vincenzo Bruzzese, E. De Martino, Maria Sole Chimenti, Flavia Sunzini, Marino Paroli, Giusy Peluso, Luca Navarini, Simonetta Salemi, Antonella Afeltra, Andrea Picchianti-Diamanti, Paola Conigliaro, Roberto Perricone, Paola Triggianese, Palma Scolieri, Elisa Gremese, D. Birra, Rossana Scrivo, Alessio Altobelli, Fabrizio Conti, Giulia Lavinia Fonti, Bruno Laganà, Rosalba Caccavale
Publikováno v:
Annals of the Rheumatic Diseases. 79:720-720
Background:Secukinumab (SEC) is the first interleukin-17A inhibitor showing efficacy in both ankylosing spondylitis (AS) and psoriatic arthritis (PsA) in randomised trials, but real-life data are lacking.Objectives:In this prospective observational s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::756b0cde849e8eec315c79118fb0d926
https://doi.org/10.1136/annrheumdis-2020-eular.3777
https://doi.org/10.1136/annrheumdis-2020-eular.3777
Autor:
G. Valesini, Stefano Calvieri, Rosalba Caccavale, Luca Bianchi, Nicoletta Bernardini, Felice Sensi, D. Birra, Severino Persechino, A. Galossi, Gaia Moretta, Dimitra Kostaki, Annamaria Mazzotta, Elisa Gremese, Dario Graceffa, Rossana Scrivo, Gian Domenico Sebastiani, Maria Concetta Potenza, Paola Sessa, Maria Sole Chimenti, S. Urbani, Roberto Perricone, C. De Simone, Antonio Giovanni Richetta, Valentina Carboni, Ketty Peris, E. Del Duca, Marino Paroli, Claudio Bonifati, Fulvia Ceccarelli, Giusy Peluso, Maria Esposito, Miriam Teoli
Publikováno v:
Saturday, 16 JUNE 2018.
Background The assessment of joint disease in psoriasis (PsO) patients is paramount, particularly where consensus among dermatology and rheumatology specialists is necessary. Objectives To evaluate the prevalence of psoriatic arthritis (PsA) in PsO p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc4287cf7e35bc1f511d4d37bc8ded0a
https://doi.org/10.1136/annrheumdis-2018-eular.3803
https://doi.org/10.1136/annrheumdis-2018-eular.3803